Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays-Reference-Cited by-同舟云学术

Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays

Published:2022-09-18 Issue:6 Volume:16 Page:2100111
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Proteomics Clinical Apps

Author:

Banerjee Arghya¹,Ray Arka²,Barpanda Abhilash¹,Dash Ankita³,Gupta Ishika⁴,Nissa Mehar Un¹,Zhu Heng⁵,Shah Abhidha⁶,Duttagupta Siddhartha P.⁷,Goel Atul⁶,Srivastava Sanjeeva¹

Affiliation:

1. Department of Biosciences and Bioengineering Indian Institute of Technology Bombay Powai Mumbai India

2. Centre for Research in Nanotechnology & Science (CRNTS) Indian Institute of Technology Bombay Powai Mumbai India

3. Miranda House University of Delhi University Enclave New Delhi Delhi India

4. Department of Biotechnology Engineering University Institute of Engineering and Technology Panjab University Chandigarh India

5. Department of Pharmacology and Molecular Sciences/High‐Throughput Biology Center Johns Hopkins University School of Medicine Baltimore, Maryland USA

6. Department of Neurosurgery at King Edward Memorial Hospital and Seth G. S. Medical College Parel Mumbai India

7. Department of Electrical Engineering Indian Institute of Technology Bombay Powai Mumbai India

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.202100111

Reference89 articles.

1. Recent advances in proteomics and its implications in pituitary endocrine disorders

2. Human Pituitary Adenoma Proteomics: New Progresses and Perspectives

3. How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020